Heron Therapeutics Company Profile (NASDAQ:HRTX)

About Heron Therapeutics

Heron Therapeutics logoHeron Therapeutics, Inc. is a biotechnology company engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Company's product candidates include SUSTOL, HTX-019 and HTX-011. All of its product candidates utilize science and technology platforms, including its Biochronomer drug delivery technology. The Company's SUSTOL (granisetron) injection, extended release is being developed for the prevention of both acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC). HTX-019, which is an intravenous formulation of aprepitant, a neurokinin-1 (NK1) receptor antagonist, is being developed for the prevention of CINV. HTX-011, a long-acting formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam, is being developed for the prevention of post-operative pain. HTX-011 is in Phase II clinical trials.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: HRTX
  • CUSIP:
Key Metrics:
  • Previous Close: $19.27
  • 50 Day Moving Average: $18.50
  • 200 Day Moving Average: $18.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.45
  • P/E Growth: -0.03
  • Market Cap: $N/A
  • Beta: 1.46
Additional Links:
Companies Related to Heron Therapeutics:

Analyst Ratings

Consensus Ratings for Heron Therapeutics (NASDAQ:HRTX) (?)
Ratings Breakdown: 9 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $47.22 (145.06% upside)

Analysts' Ratings History for Heron Therapeutics (NASDAQ:HRTX)
Show:
DateFirmActionRatingPrice TargetDetails
8/18/2016Leerink SwannReiterated RatingOutperform$33.00View Rating Details
8/13/2016Brean CapitalReiterated RatingBuy$55.00View Rating Details
8/9/2016Cantor FitzgeraldReiterated RatingBuy$38.00View Rating Details
7/27/2016Jefferies GroupReiterated RatingBuy$46.00View Rating Details
7/9/2016Cowen and CompanyReiterated RatingBuyView Rating Details
4/20/2016Noble FinancialReiterated RatingBuy$51.00View Rating Details
1/15/2016Lake Street CapitalReiterated RatingBuy$45.00View Rating Details
9/24/2015JMP SecuritiesReiterated RatingBuyView Rating Details
9/24/2015Bank of America Corp.Boost Price TargetBuy$54.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Heron Therapeutics (NASDAQ:HRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/8/2016Q2($0.96)($1.17)ViewN/AView Earnings Details
5/5/2016Q1($0.92)($0.92)ViewN/AView Earnings Details
2/19/2016Q4($0.64)($0.87)ViewN/AView Earnings Details
11/6/2015Q3($0.67)($0.63)ViewN/AView Earnings Details
8/7/2015($0.65)($0.74)ViewN/AView Earnings Details
5/8/2015Q115($0.68)($0.70)ViewN/AView Earnings Details
3/13/2015($0.79)($0.71)ViewN/AView Earnings Details
11/6/2014($0.69)($0.66)ViewN/AView Earnings Details
8/4/2014($0.62)($0.78)ViewN/AView Earnings Details
5/8/2014($0.67)($0.74)ViewN/AView Earnings Details
3/5/2014($0.53)($0.75)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Heron Therapeutics (NASDAQ:HRTX)
Current Year EPS Consensus Estimate: $-4.32 EPS
Next Year EPS Consensus Estimate: $-2.04 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($1.21)($0.90)($1.06)
Q2 20163($0.98)($0.92)($0.95)
Q3 20163($1.19)($0.86)($1.04)
Q4 20163($1.20)($0.75)($0.94)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Heron Therapeutics (NASDAQ:HRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Heron Therapeutics (NASDAQ:HRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/10/2016Robert RosenInsiderSell100,000$23.30$2,330,000.00View SEC Filing  
4/21/2016Robert RosenPresidentSell200,000$23.23$4,646,000.00View SEC Filing  
6/10/2015Kevin C TangDirectorBuy121,212$24.75$2,999,997.00View SEC Filing  
6/2/2015Kevin C TangDirectorBuy150,000$20.62$3,093,000.00View SEC Filing  
6/1/2015Kimberly ManhardDirectorSell2,708$21.17$57,328.36View SEC Filing  
6/25/2014Barry D QuartCEOBuy10,000$11.75$117,500.00View SEC Filing  
6/25/2014Kevin C TangDirectorBuy510,638$11.75$5,999,996.50View SEC Filing  
11/20/2013Barry D QuartCEOBuy1,000,000$0.40$400,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Heron Therapeutics (NASDAQ:HRTX)
DateHeadline
News IconHeron Therapeutics Inc. (NASDAQ: HRTX) Outperform Rating Reiterated at Leerink Swann - BNB Daily (blog) (NASDAQ:HRTX)
www.baseball-news-blog.com - August 19 at 5:28 PM
finance.yahoo.com logoHERON THERAPEUTICS, INC. /DE/ Financials (NASDAQ:HRTX)
finance.yahoo.com - August 17 at 5:44 PM
investornewswire.com logoWill Heron Therapeutics, Inc. (NASDAQ:HRTX) Hit $55 Price Target? - Investor Newswire (NASDAQ:HRTX)
www.investornewswire.com - August 17 at 8:33 AM
finance.yahoo.com logoBeyond SUSTOL: Why Heron (HRTX) is a Great Biotech Stock to Buy (NASDAQ:HRTX)
finance.yahoo.com - August 15 at 5:45 PM
thestreet.com logoBiotech Stock Mailbag: Heron, Acadia, Exact Sciences, Sarepta (NASDAQ:HRTX)
www.thestreet.com - August 12 at 8:37 AM
News IconHeron’s (HRTX) Sustol For Chemotherapy-Induced Nausea Approved By FDA In Third Attempt (NASDAQ:HRTX)
www.ibtimes.com - August 11 at 8:31 AM
finance.yahoo.com logoBulls target upside in Heron Therapeutics (NASDAQ:HRTX)
finance.yahoo.com - August 11 at 8:31 AM
marketwatch.com logoHeron Therapeutics shares rise 18% in pre-market trade after company said treatment was approved by FDA - MarketWatch (NASDAQ:HRTX)
www.marketwatch.com - August 10 at 5:47 PM
schaeffersresearch.com logoFDA Nod Sets Heron Therapeutics Inc (HRTX) Options on Fire - Schaeffers Research (blog) (NASDAQ:HRTX)
www.schaeffersresearch.com - August 10 at 5:47 PM
biz.yahoo.com logoHERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi (NASDAQ:HRTX)
biz.yahoo.com - August 10 at 5:47 PM
investors.com logoHeron Therapeutics receives FDA approval for anti-nausea drug (NASDAQ:HRTX)
www.proactiveinvestors.com - August 10 at 12:28 PM
forbes.com logoNoteworthy Wednesday Option Activity: GD, HRTX, LMT (NASDAQ:HRTX)
www.forbes.com - August 10 at 12:28 PM
marketwatch.com logoHeron Therapeutics shares halted before company said treatment approved by FDA (NASDAQ:HRTX)
www.marketwatch.com - August 10 at 12:28 PM
streetinsider.com logoHeron Therapeutics (HRTX) Reports FDA Approval of SUSTOL (NASDAQ:HRTX)
www.streetinsider.com - August 10 at 12:28 PM
schaeffersresearch.com logoFDA Nod Sets Heron Therapeutics Inc (HRTX) Options on Fire (NASDAQ:HRTX)
www.schaeffersresearch.com - August 10 at 12:28 PM
biz.yahoo.com logoHeron Therapeutics Inc U.S. FDA Approval of SUSTOL Extended-Release Injection Call scheduled for 9:00 am ET today (NASDAQ:HRTX)
biz.yahoo.com - August 10 at 12:28 PM
marketwatch.com logoHeron Therapeutics shares rise 18% in pre-market trade after company said treatment was approved by FDA (NASDAQ:HRTX)
www.marketwatch.com - August 10 at 12:28 PM
wsj.com logo[$$] FDA Approves Heron Therapeutics's Sustol (NASDAQ:HRTX)
www.wsj.com - August 10 at 12:28 PM
News IconHeron Reports Second Quarter 2016 Financial Results and Recent Corporate Progress (NASDAQ:HRTX)
www.biospace.com - August 9 at 4:19 PM
twst.com logoHeron Therapeutics Inc.: Heron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress (NASDAQ:HRTX)
www.twst.com - August 9 at 8:28 AM
sg.finance.yahoo.com logoHeron Therapeutics reports 2Q loss (NASDAQ:HRTX)
sg.finance.yahoo.com - August 8 at 5:41 PM
publicnow.com logoHeron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress (NASDAQ:HRTX)
www.publicnow.com - August 8 at 5:41 PM
equities.com logoHeron Therapeutics Inc (HRTX) Jumps 6.76% on August 03 ... - Equities.com (NASDAQ:HRTX)
www.equities.com - August 5 at 5:38 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Aratana Therapeutics, Dynavax Technologies, Heron Therapeutics and La Jolla Pharmaceutical (NASDAQ:HRTX)
finance.yahoo.com - August 5 at 5:38 PM
equities.com logoHeron Therapeutics Inc (HRTX) is Trading Higher on Unusual Volume for August 02 - Equities.com (NASDAQ:HRTX)
www.equities.com - August 5 at 8:27 AM
equities.com logoHeron Therapeutics Inc (HRTX) Jumps 7.69% on August 02 (NASDAQ:HRTX)
www.equities.com - August 4 at 5:49 PM
smarteranalyst.com logoCompany Update (NASDAQ:HRTX): Heron Therapeutics Inc Enters Into Loan Agreement for Up to $100 Million (NASDAQ:HRTX)
www.smarteranalyst.com - August 3 at 5:50 PM
streetupdates.com logoMost Recent Analysts Ratings Report: Heron Therapeutics, Inc ... - Street Updates (NASDAQ:HRTX)
www.streetupdates.com - August 3 at 8:44 AM
News IconXerox Corp (NYSE:XRX) & Heron Therapeutics (NASDAQ:HRTX) Hot Stock's Alert - Money News (press release) (NASDAQ:HRTX)
www.newsismoney.com - August 3 at 8:44 AM
smarteranalyst.com logoCompany Update (NASDAQ:HRTX): Heron Therapeutics Inc Enters Into Loan Agreement for Up to $100 Million - Smarter Analyst (NASDAQ:HRTX)
www.smarteranalyst.com - August 3 at 8:44 AM
insidermonkey.com logoWhat’s In The Latest Heron Therapeutics Inc (HRTX) Data? (NASDAQ:HRTX)
www.insidermonkey.com - August 2 at 5:46 PM
smarteranalyst.com logoStock Update (NASDAQ:HRTX): Heron Therapeutics Inc Reports Positive Top-Line ... (NASDAQ:HRTX)
www.smarteranalyst.com - August 2 at 10:18 AM
marketexclusive.com logoWhat’s In The Latest Heron Therapeutics Inc (NASDAQ:HRTX) Data? (NASDAQ:HRTX)
marketexclusive.com - August 2 at 10:18 AM
publicnow.com logoHeron Therapeutics Enters into Loan Agreement for Up to $100 Million (NASDAQ:HRTX)
www.publicnow.com - August 2 at 10:18 AM
News IconTrending Gainers of the Day: Ionis Pharmaceuticals, (NASDAQ:IONS), Heron Therapeutics, (NASDAQ:HRTX) - Financial Breaking News (press release) (NASDAQ:HRTX)
wsbreakingnews.com - August 1 at 5:25 PM
fortune.com logoPre-Market Investor's Watch List: SolarCity Corp. (NASDAQ:SCTY), Heron Therapeutics Inc(NASDAQ:HRTX) - Review Fortune (NASDAQ:HRTX)
reviewfortune.com - August 1 at 5:25 PM
smarteranalyst.com logoStock Update (NASDAQ:HRTX): Heron Therapeutics Inc Reports Positive Top-Line Results from Phase 2 Studies of ... - Smarter Analyst (NASDAQ:HRTX)
www.smarteranalyst.com - August 1 at 5:25 PM
twst.com logoHeron Therapeutics Inc.: Heron Therapeutics Reports Positive Top-Line Results from Phase 2 Studies of HTX-011 for Management of Post-Operative Pain (NASDAQ:HRTX)
www.twst.com - August 1 at 10:13 AM
publicnow.com logoHeron Therapeutics Reports Positive Top-Line Results from Phase 2 Studies of HTX-011 for Management of Post-Operative Pain (NASDAQ:HRTX)
www.publicnow.com - August 1 at 6:31 AM
biz.yahoo.com logoHERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:HRTX)
biz.yahoo.com - August 1 at 6:14 AM
finance.yahoo.com logo6:01 am Heron Therapeutics announces preliminary, 'positive', top-line efficacy results from two Phase 2 clinical studies of HTX-011 for the management of post-operative pain in patients undergoing bunionectomy and inguinal hernia repair (NASDAQ:HRTX)
finance.yahoo.com - August 1 at 6:01 AM
equities.com logoHeron Therapeutics Inc (HRTX) Drops 8.27% on July 28 (NASDAQ:HRTX)
www.equities.com - July 30 at 5:01 PM
equities.com logoHeron Therapeutics Inc (HRTX) Drops 8.27% on July 28 - Equities.com (NASDAQ:HRTX)
www.equities.com - July 30 at 8:22 AM
equities.com logoHeron Therapeutics Inc (HRTX) Jumps 9.87% on July 27 (NASDAQ:HRTX)
www.equities.com - July 28 at 5:39 PM
equities.com logoHeron Therapeutics Inc (HRTX) Jumps 9.87% on July 27 - Equities.com (NASDAQ:HRTX)
www.equities.com - July 28 at 8:27 AM
investornewswire.com logoCan Shares Of Heron Therapeutics, Inc. (NASDAQ:HRTX) Hit $55? - Investor Newswire (NASDAQ:HRTX)
www.investornewswire.com - July 27 at 8:16 AM
benzinga.com logoSlingshot Insights Expert Discusses Sustol Delays (NASDAQ:HRTX)
www.benzinga.com - July 22 at 5:27 PM
ftsenews.co.uk logoNew Broker Ratings For Heron Therapeutics Inc (HRTX) - FTSE News (NASDAQ:HRTX)
www.ftsenews.co.uk - July 22 at 8:27 AM
equities.com logoHeron Therapeutics Inc (HRTX) Drops 6.3% on July 19 (NASDAQ:HRTX)
www.equities.com - July 21 at 5:41 PM
News IconHeron Therapeutics, Inc. (NASDAQ:HRTX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:HRTX)
www.engelwooddaily.com - July 21 at 11:32 AM

Social

Heron Therapeutics (NASDAQ:HRTX) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff